Ara-C drug
Evidence from:
primary |
all sources
Related entities (1)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| Neurobasal | associated_with | Ara-C | — | 1 |
Mentioned in (7)
Papers in which this entity is mentioned.
- NUP98-NSD1 Driven MDS/MPN in Childhood Masquerading as JMML. (2021)
- Differential sensitivity of human neurons carrying μ opioid receptor (MOR) N40D variants in response to ethanol. (2020)
- Super-enhancers: critical roles and therapeutic targets in hematologic malignancies. (2019)
- How I diagnose and manage Philadelphia chromosome-like acute lymphoblastic leukemia. (2019)
- Small molecule inhibition of cAMP response element binding protein in human acute myeloid leukemia cells. (2016)
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. (2012)
- Recurring mutations found by sequencing an acute myeloid leukemia genome. (2009)
Merged raw entities (4)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| cytarabine | drug | 7 | 11 |
| ara-c | drug | 3 | 6 |
| cytosine arabinoside | drug | 2 | 3 |
| c1648 | drug | — | — |